Soc. Generale Knock-Out Aegon Ltd.../ DE000SU22N37 /
21/06/2024 08:46:04 | Var.+0.06 | Denaro07:56:31 | Lettera07:56:31 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
1.11EUR | +5.71% | 1.06 Quantità in denaro: 2,900 |
1.10 Quantità in lettera: 2,900 |
- | 4.8421 EUR | 31/12/2078 | Call |
GlobeNewswire
08:00
First gene therapy for prevalent pathologies in neurology receives FDA IND clearance - EG 427 initi...
GlobeNewswire
07:30
PolTREG’s type-1 diabetes Treg cell therapy PTG-007 demonstrates long-term safety and efficacy for u...
GlobeNewswire
07:30
OSE Immunotherapeutics Announces Commercial and Revenue Sharing Agreement in the Field of CAR T-cell...
GlobeNewswire
07:00
Valneva Announces Health Canada Approval of the World’s First Chikungunya Vaccine, IXCHIQ®
GlobeNewswire
06:20
China's Hangzhou empowers urban development with world-class power supply reliability
GlobeNewswire
03:00
SALESFORCE ALERT: Bragar Eagel & Squire, P.C. is Investigating Salesforce, Inc. on Behalf of Salesfo...
GlobeNewswire
03:00
NIKE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against...